Skip to main content Accessibility help
×
  1. Home
  2. Books
  3. Core Topics in Endocrinology in Anaesthesia and Critical Care
  • Cited by 5
      • Show more authors
      • You may already have access via personal or institutional login
    • Select format
    • Publisher:
      Cambridge University Press
      Publication date:
      06 July 2010
      01 April 2010
      ISBN:
      9780511750441
      9780521509992
      DOI:
      https://doi.org/10.1017/CBO9780511750441
      Dimensions:
      (246 x 189 mm)
      Weight & Pages:
      0.61kg, 202 Pages
      Dimensions:
      Weight & Pages:
      • Subjects:
      Anesthesia, Intensive Care, Pain Management, Medicine
    You may already have access via personal or institutional login
    • Selected: Digital
    Add to cart View cart Buy from Cambridge.org
    Subjects:
    Anesthesia, Intensive Care, Pain Management, Medicine
    Information

    Book description

    Core Topics in Endocrinology in Anesthesia and Critical Care provides a comprehensive, practical overview of the perioperative management of patients with endocrine disorders, giving clear diagnostic advice and management guidelines. This book considers the management of patients with endocrine disorders of the pituitary, thyroid, parathyroid and adrenal glands, including rarer disorders such as MEN syndrome. It then considers all aspects of the perioperative management of diabetic patients, including paediatric, obstetric and ambulatory patients. Finally it discusses endocrine disorders in the critically ill patient, covering such issues as the topical conundrum of glucose control and the management of diabetic metabolic acidosis, thyroid storm and myxoedema coma. Every chapter reviews the relevant anatomy and pathophysiology and the latest developments in defining the genetic causes are also considered where appropriate. Core Topics in Endocrinology in Anesthesia and Critical Care is an invaluable tool for all anaesthetists and intensivists in their daily clinical practice.

    Refine List

    Actions for selected content:

    Select all | Deselect all
    • View selected items
    • Export citations
    • Download PDF (zip)
    • Save to Kindle
    • Save to Dropbox
    • Save to Google Drive

    Save Search

    You can save your searches here and later view and run them again in "My saved searches".

    Please provide a title, maximum of 40 characters.
    Cancel
    ×

    Contents

    Contents
    • Chapter 8 - Drugs used in diabetes mellitus
      pp 83-92
    • View abstract

      Summary

      The human neuroendocrine system has two components, hormonal secretion that is controlled by hypothalamo-pituitary axis and extra-hypothalamic neurohormones. Hypothalamus is responsible for the maintenance of homeostasis and the integration of nervous and endocrine control mechanisms. It regulates many of the body's autonomic functions, such as temperature, thirst and hunger, blood pressure and volume, sleep and sexual function, and is intimately related, both anatomically and functionally, to the pituitary gland. The majority of clinically significant pituitary conditions are the result of tumour or tumour-like conditions that arise from either within the gland itself or in surrounding parasellar tissues. The endocrine hyposecretion syndromes associated with pituitary disease of relevance to perioperative care include adrenocortical insufficiency, hypothyroidism and diabetes insipidus. Sellar or parasellar lesions rarely present with failure of posterior lobe function, although it is a relatively frequent complication of surgical resection.
    • Chapter 10 - Management of diabetes in obstetric patients
      pp 101-108
    • View abstract

      Summary

      Many patients who require anaesthesia have coincidental disease of their thyroid gland. The thyroid gland is situated in the anterior region of the neck just deep to the strap muscles at the level of the C5 to T1 vertebrae. The structural units of the thyroid gland consist of round follicles, or acini, filled with colloid and surrounded by a single layer of epithelial thyroid cells. The signs and symptoms of hypothyroidism are predictable consequences of the physiological effects of the lack of thyroid hormones. Thyrotoxicosis affects approximately 2% of women and 0.2% of men in the general population. The prevalence of hyperthyroidism in iodine-sufficient areas is 2:1000 for overt and 6:1000 for sub-clinical hyperthyroidism. The indications for thyroidectomy include thyroid malignancy, obstructive symptoms, retrosternal goitre, Graves' disease unresponsive to medical treatment, recurrent hyperthyroidism, occasionally Hashimoto's disease and for cosmetic reasons.
    • Chapter 11 - Management of diabetes in paediatric surgery
      pp 109-116
    • View abstract

      Summary

      This chapter considers the basic anatomy and physiology of the parathyroid gland, followed by its pathologies and their implications for anaesthesia. There are usually two pairs of parathyroid gland, superior and inferior, each measuring 4 x 2 x 6 mm, surrounded by fat and each weighing approximately 25-40 mg. About 80-90% of patients have four parathyroids. Parathyroid hormone is secreted by the parathyroid chief cells in response to the fall in the level of circulating, free calcium. The clinical presentation of primary hyperparathyroidism has altered over the past century. It is a commonly recognised endocrine disorder, with the number of parathyroidectomies increasing each year. The gold standard of treatment and the only hope of cure is surgical parathyroidectomy. Preoperative intravenous infusion of methylene blue is used to identify the parathyroid glands, and in open or minimally invasive surgery the operative times can be reduced.
    • Chapter 12 - Management of diabetes in ambulatory surgery
      pp 117-124
    • View abstract

      Summary

      The adrenal glands are located at the upper margin of the kidneys about the level of the 12th thoracic vertebra. They are composed of two functional parts, the medulla and the cortex. Disease processes of the adrenal glands that may require surgical intervention result from excessive secretion of one or more of these hormones. A secretory tumour of the medulla is known as a phaeochromocytoma, which produces high circulating concentrations of catecholamines. In the cortex, benign secretory adenomas can produce cortisol resulting in high circulating levels (Cushing's disease) or secrete aldosterone (Conn's syndrome). Prolonged treatment with steroids such as prednisolone can produce secondary adrenocortical insufficiency due to suppression of the normal control mechanisms. This results in profound cardiovascular collapse in the perioperative period. This severe complication can be avoided by supplementation with cortisol.
    • Section 3 - Endocrine disorders in the critically ill
      pp 125-184
    • View abstract

      Summary

      Pancreatic islet cell tumours and carcinoids are rare, and patients with these tumours form a small part of the case-load of the anaesthetist who regularly undertakes anaesthesia for major abdominal surgery. Insulinoma is the commonest functioning pancreatic neuroendocrine tumour (NET). Gastrinoma is the second commonest functioning pancreatic neuroendocrine tumour, and contrasts with insulinoma in several respects. The absence of symptoms is characteristic of non-functioning tumours. VIPoma is a rare tumour. Secretion of Vasoactive Intestinal Polypeptide produces watery diarrhea. Major upper abdominal surgery involves a bilateral subcostal incision, may last for several hours, requires dissection of lymphatic tissue and causes fluid shifts. It occasionally results in severe blood loss. A. Holdcroft has described a pre-operative checklist for the additional problems of the patient with a NET. Pre-operative investigations include pulmonary function tests, ECG, full blood count, clotting screen, electrolytes and liver function tests.
    • Chapter 14 - Tight glucose control using intensive insulin therapy in the critically ill
      pp 134-143
    • View abstract

      Summary

      Multiple endocrine neoplasia (MEN) is a rare autosomal dominant disorder characterised by primary tumours in at least two different endocrine glands. In the early twentieth century, a syndrome that involved the concurrence of tumours of the parathyroid glands, the pancreatic islets and the anterior pituitary gland was described. The gene that codes for menin is located on chromosome 11q12-13 and transcribes an mRNA consisting of 10 exons which encodes the 610 amino acid protein, menin. MEN 2 is a rare disorder with a prevalence of one in 20,000, and like MEN 1, is an dominant syndrome. The RET protooncogene, located on chromosome 10q11.2, transcribes an mRNA consisting of 21 exons. Molecular information has revolutionised the understanding and treatment of MEN 2. The increasing knowledge of the molecular mechanisms of MEN coupled with the clinical outcome and the availability of genetic testing has greatly reduced its morbidity and mortality.
    • Chapter 15 - Glucocorticoids in the critically ill
      pp 144-154
    • View abstract

      Summary

      The International Diabetes Federation estimated that in 2008 there were 246 million adults worldwide with diabetes mellitus (DM), and the prevalence is expected to reach at least 380 million by 2025. Diabetes is diagnosed on the basis of criteria agreed by the World Health Organization (WHO) in 1999. Destruction of the pancreatic ß-cells is characteristic of type 1 DM and usually results in an absolute deficiency of insulin. The principles of management of type 1 DM are based on the detailed observations made in two major trials; the Diabetes Control and Complications Trial (DCCT) and the subsequent Epidemiology of Diabetes Interventions and Complications study (EDIC). Hypoglycaemia is a major concern for many type 1 diabetic patients and is usually described as mild, moderate or severe. Most of the increased morbidity and mortality associated with DM is the result of the micro- and macrovascular complications.
    • Chapter 17 - Thyroid dysfunction and critical care
      pp 168-174
    • View abstract

      Summary

      Diabetes mellitus (DM) is characterised by an absolute or relative deficiency of insulin. There are currently eight different pharmacological classes of anti-diabetic agents. These include agents that increase insulin secretion, improve insulin action and delay carbohydrate absorption. The classes of anti-diabetic agents are sulphonylureas, meglitinides, biguanides, thiazolidinediones, α-glucosidase inhibitors, GLP-1 (glucagon-like peptide-1) receptor agonists, DPP-4 (dipeptidyl peptidase-4) inhibitors and synthetic amylin analogues. Sulphonylureas are known as insulin secretagogues as their major mechanism of action is to increase insulin secretion. The glinides are newer insulin secretagogues that include the meglitinide, repaglinide, and a benzoic acid derivative, and the amino acid derivative, nateglinide. Metformin and phenformin were introduced for the therapy of DM in the 1950s. Thiazolidinediones (TZDs), like metformin, belong to the class of drugs known as insulin sensitisers. Incretins are gut-derived peptides secreted in response to meals, specifically the presence and absorption of nutrients in the intestinal lumen.
    • Chapter 18 - Disorders of sodium balance
      pp 175-184
    • View abstract

      Summary

      Surgery may be undertaken for the complications of diabetes mellitus (DM), such as coronary artery disease, peripheral vascular disease and renal failure, or the diabetes may be unrelated to the surgical procedure. The aims of metabolic management perioperatively are to avoid hypoglycaemia, excessive hyperglycaemia, and minimise lipolysis and proteolysis by the provision of exogenous glucose and insulin. In the virtual absence of clinical studies in general surgery, and considering the basic biological data on the harmful effects of hyperglycaemia, it is reasonable to recommend that blood glucose should be maintained in the range of 6-10 mmol l-1. There is general agreement that all type 1 diabetic patients should be managed with an intravenous glucose-insulin-potassium (GIK) infusion for inpatient surgery. It is common practice to administer the glucose infusion in the GIK regimen at 100-125 ml h-1.

    Metrics

    Altmetric attention score

    Full text views

    Total number of HTML views: 0
    Total number of PDF views: 0 *
    Loading metrics...

    Book summary page views

    Total views: 0 *
    Loading metrics...

    * Views captured on Cambridge Core between #date#. This data will be updated every 24 hours.

    Usage data cannot currently be displayed.

    Accessibility standard: Unknown

    Why this information is here

    This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

    Accessibility Information

    Accessibility compliance for the HTML of this book is currently unknown and may be updated in the future.